NEW YORK, March 31 - Cyclacel said today that it has entered a four-way collaboration with several private and public partners to develop RNA interference (RNAi) technology for target validation and drug discovery.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers describe a way to share data while keeping it secure, Agence France Presse reports.
In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.
India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.
A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.